Recent Patents On Anti-Cancer Drug Discovery impact factor, indexing, ranking (2022)


Recent

Aim and Scope

Recent Patents On Anti-Cancer Drug Discovery is a research journal that publishes research related to Pharmacology (medical). This journal is published by the Bentham. The P-ISSN of this journal is 15748928.

Also, check the other important details below like Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate of Recent Patents on Anti-Cancer Drug Discovery.

Recent Patents On Anti-Cancer Drug Discovery Ranking

Impact Factor: 3.038
Total Citations: 993
SJR (SCImago Journal Rank): 0.71
Quartile: Q2

The Impact Factor of Recent Patents On Anti-Cancer Drug Discovery is 3.038.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Important Metrics

Journal Title: Recent Patents on Anti-Cancer Drug Discovery
Publisher: Bentham
P-ISSN: 15748928
Open Access: NO
Subject: Pharmacology (medical)
Citescore: 5.1
SNIP: 0.88
SJR: 0.71
Quartile: 2

Recent Patents on Anti-Cancer Drug Discovery Indexing

The Recent Patents on Anti-Cancer Drug Discovery is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Recent Patents On Anti-Cancer Drug Discovery Impact Factor 2022

The latest impact factor of Recent Patents on Anti-Cancer Drug Discovery is 3.038.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.


Recent Patents On Anti-Cancer Drug Discovery Quartile

The latest Quartile of Recent Patents on Anti-Cancer Drug Discovery is Q2.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Recent Patents On Anti-Cancer Drug Discovery?

This journal covers the fields/ categories related to Pharmacology (medical). If your research field is related to Pharmacology (medical), then visit the official website of Recent Patents on Anti-Cancer Drug Discovery and send your manuscript.

Tips for publishing in Recent Patents On Anti-Cancer Drug Discovery:

  • Selection of research problem.
  • Presenting a solution.
  • Designing the paper.
  • Make your manuscript publication worthy.
  • Write an effective results section.
  • Mind your references.

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Even you can Contact the editor of the journal.

Journal Review Time

Journals usually ask reviewers to provide their reviews within 3-4 weeks. However, few journals have a mechanism to enforce the deadline, which is why it can be hard to predict how long the peer review process will take.

The review time also depends upon the quality of a research paper.


Final Summary

  • The impact factor of Recent Patents on Anti-Cancer Drug Discovery is 3.038.
  • It is published by Bentham.
  • The journal is indexed in UGC CARE, Scopus, SCIE.
  • The (SJR) SCImago Journal Rank is 0.71.
  • The Recent Patents on Anti-Cancer Drug Discovery is a reputed research journal.

Sources:

https://www.scopus.com/sourceid/5800173385







Similiar Journals


CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
ISSN: 1084-9785
Publisher: MARY ANN LIEBERT, INC

DOSE-RESPONSE
ISSN: 1559-3258
Publisher: SAGE PUBLICATIONS INC

PHARMACEUTICAL BIOLOGY
ISSN: 1388-0209
Publisher: TAYLOR & FRANCIS LTD

THERAPEUTIC DRUG MONITORING
ISSN: 0163-4356
Publisher: LIPPINCOTT WILLIAMS & WILKINS

THERAPEUTIC INNOVATION & REGULATORY SCIENCE
ISSN: 2168-4790
Publisher: SPRINGER HEIDELBERG

3D PRINTING IN MEDICINE
ISSN: 2365-6271
Publisher: SPRINGERNATURE

ACTA RADIOLOGICA OPEN
ISSN: 2058-4601
Publisher: SAGE PUBLICATIONS LTD

ADVANCES IN RADIATION ONCOLOGY
ISSN: 2452-1094
Publisher: ELSEVIER INC

AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
ISSN: 2160-8407
Publisher: E-CENTURY PUBLISHING CORP

APPLIED RADIOLOGY
ISSN: 0160-9963
Publisher: ANDERSON PUBLISHING, INC

Top 20 Journals

Credit and Source: Scopus, Clarivate, UGC CARE.